Výsledky vyhledávání - C-F. Chiu
- Zobrazuji výsledky 1 - 8 z 8
-
1
CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocar... Autor L-T. Chen, Andrea Wang‐Gillam, Y-S Shan, T. Macarulla Mercadé, Jan Blanc, Richard Hubner, C-F. Chiu, G. Schwartsmann, J. Siveke, Bruce Belanger, F. de Jong, K. Mamlouk, D. Von Hoff
Vydáno 2017Artigo -
2
Capsaicin mediates apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells through mitochondrial depolarization and endoplasmic reticulum stress Autor S-W Ip, Sheng‐Hui Lan, H-F Lu, A-C Huang, Jai‐Sing Yang, J-P Lin, H-Y Huang, J‐C Lien, C-C Ho, C-F. Chiu, WG Wood, J-G Chung
Vydáno 2011Artigo -
3
Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households Autor Benjamin J. Cowling, Rita O. P. Fung, C. Cheng, Vicky J. Fang, Kwok Hung Chan, WH Seto, R Yung, Billy C.F. Chiu, Paco Lee, Timothy M. Uyeki, Peter M. Houck, Malik Peiris, GM Leung
Vydáno 2008Artigo -
4
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C Autor Ming‐Lung Yu, CY Dai, Jee‐Fu Huang, Nan Hou, L.-P. Lee, Meng‐Hsuan Hsieh, C.-F. Chiu, Lin Zhong, Szu‐Chia Chen, Meng‐Hsuan Hsieh, Liping Wang, Wen‐Yu Chang, Wan‐Long Chuang
Vydáno 2006Artigo -
5
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: a phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocar... Autor J.-F. Blanc, Richard Hubner, Li Cp, Andrea Wang‐Gillam, Gyorgy Bodoky, A. Dean, Y-S Shan, Gayle Jameson, T. Macarulla Mercadé, KH Lee, David Cunningham, C-F. Chiu, G. Schwartsmann, Fadi Braiteh, D. Von Hoff, L-T. Chen, K. Mamlouk, F. de Jong, J. Siveke
Vydáno 2017Artigo -
6
NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progres... Autor Daniel D. Von Hoff, C.P. Li, Andrea Wang‐Gillam, G. Bodoky, Andrew Dean, Gayle Jameson, Teresa Macarulla, K.H. Lee, David Cunningham, Jean‐Frédéric Blanc, Richard Hubner, C.-F. Chiu, Gilberto Schwartsmann, Jens T. Siveke, Fadi Braiteh, Victor Moyo, Bruce Belanger, Navreet Dhindsa, E. Bayever, Liang-Yi Chen
Vydáno 2014Artigo -
7
Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with g... Autor L.-T. Chen, Andrea Wang‐Gillam, C.-P. Li, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Ki Hoon Lee, David Cunningham, J.-F. Blanc, Richard Hubner, C.-F. Chiu, Gilberto Schwartsmann, Fadi Braiteh, Bruce Belanger, E. Bayever, F. de Jong, Daniel D. Von Hoff, Jens T. Siveke
Vydáno 2016Artigo -
8
Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastati... Autor Richard Hubner, L.-T. Chen, Jens T. Siveke, C.-P. Li, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Ki Hoon Lee, David Cunningham, J.-F. Blanc, C.-F. Chiu, Gilberto Schwartsmann, Fadi Braiteh, Khalid Mamlouk, Bruce Belanger, F. de Jong, Daniel D. Von Hoff, Andrea Wang‐Gillam
Vydáno 2016Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Gastroenterology
Cancer
Colorectal cancer
Fluorouracil
Irinotecan
Surgery
Urology
Chemotherapy
Gemcitabine
Randomized controlled trial
Clinical endpoint
Incidence (geometry)
Nausea
Nuclear medicine
Optics
Phases of clinical research
Physics
Adenocarcinoma
Adverse effect
Anemia
Apoptosis
Attack rate
Biochemistry
Biology
Cancer research
Capsaicin
Caspase
Cell biology